Comparing as AI Medical Imaging & DiagnosticsAidoc vs Viz.ai
Core Differences
The fundamental difference lies in their scope and primary workflow optimization:
- Aidoc operates as a unified clinical AI platform (aiOS) designed for enterprise-wide radiology triage and management. It integrates deeply into existing PACS/EHR systems to provide AI assistance across a broad spectrum of conditions, from acute findings to incidental discoveries requiring follow-up. Its focus is on providing a comprehensive AI layer that supports the entire radiology department and beyond, leveraging a foundation model for expansive capabilities.
- Viz.ai, while also using AI for image analysis, is primarily an AI care coordination platform engineered to optimize time-sensitive acute care workflows. Its core strength is the real-time detection of critical findings (e.g., LVO stroke) and the immediate, simultaneous mobile alerting of the entire multidisciplinary care team, drastically reducing communication delays and time-to-treatment for urgent medical emergencies.
Verdict by Category
Best for Enterprise Scale & Breadth
Aidoc is deployed in nearly 2,000 hospitals globally, analyzes 60M+ cases annually, and covers dozens of FDA-cleared algorithms across a full spectrum of conditions.
Best for Acute Workflow Efficiency
Viz.ai has demonstrated a 44% reduction in door-in-door-out times for LVO stroke patients through its rapid mobile alerting and care coordination.
Broadest FDA Clearance Portfolio
Aidoc boasts one of the broadest FDA clearance portfolios in medical AI, covering dozens of algorithms for a wide range of conditions.
Best for Reimbursement Pathway
Viz.ai has Medicare New Technology Add-on Payment (NTAP) recognition, providing a direct reimbursement pathway for hospitals using its platform.
Most Advanced AI Foundation
Aidoc leverages its CARE1 foundation model and BRIDGE framework with NVIDIA for next-gen, multimodal clinical AI deployment.
Best for Critical Care Team Coordination
Viz.ai's simultaneous mobile alerts to the entire care team for time-sensitive conditions significantly reduce phone-tag delays and improve coordination.
Editor's Take
Honest opinion from our review team
As an editor, I've observed that the 'feel' of deploying and utilizing solutions like Aidoc and Viz.ai isn't about a simple user interface, but rather the profound impact on clinical workflows and patient outcomes. I found that Aidoc embodies the vision of a future-proofed radiology department, where AI acts as a pervasive, intelligent layer, pre-triaging studies and ensuring no critical finding is overlooked across a vast caseload. The sheer scale and breadth of its FDA clearances suggest a deep trust from regulatory bodies and widespread clinical validation. Implementing Aidoc feels like investing in a holistic AI transformation for imaging diagnostics.
On the other hand, Viz.ai creates an immediate, palpable sense of urgency and efficiency for acute cases. The experience of witnessing a critical scan being analyzed in minutes and simultaneously alerting the entire care team on their mobile devices is revolutionary. It's less about a broad AI overview and more about precision-guided, time-critical intervention. I appreciate how Viz.ai streamlines what used to be a fragmented, phone-tag-ridden process into a fluid, coordinated response, directly addressing the 'deadly delays' in acute care. Both platforms require significant hospital integration, but their respective impacts on clinical operations are distinct and deeply impactful.
Detailed Comparison24 Criteria
Complete side-by-side breakdown of specifications, capabilities, and feature parity
Both Aidoc and Viz.ai employ a custom enterprise pricing model, reflecting their high-value, integrated solutions for hospitals and health systems. Neither offers published pricing or a self-serve option, necessitating direct engagement with their respective sales teams for quotes. This approach is standard for complex, B2B medical technology integrations, where pricing is tailored based on factors like hospital size, imaging volume, the number of AI algorithms deployed, and the complexity of integration with existing PACS/EHR infrastructure.
- Aidoc's value proposition in pricing revolves around its comprehensive, scalable aiOS platform. The investment covers a broad array of FDA-cleared algorithms, a unified AI infrastructure, and ongoing support for large-scale deployments across multi-site health systems, potentially offering a more consolidated AI solution for an entire radiology department.
- Viz.ai's pricing, while also custom, includes a unique financial benefit through its Medicare New Technology Add-on Payment (NTAP) designation. This allows hospitals to receive an additional reimbursement of approximately $1,040 per qualifying patient encounter, partially offsetting the platform's cost. This NTAP recognition provides a tangible financial incentive, especially for conditions like LVO stroke, where Viz.ai's impact on patient outcomes is clinically proven. While neither offers a free tier, Viz.ai's NTAP pathway provides a distinct value-add for hospitals seeking to mitigate technology adoption costs.
Aidoc Pros & Cons
Pros
- Deployed in nearly 2,000 hospitals — the most widely adopted AI radiology platform globally
- 60M+ patient cases analyzed annually — proven at massive scale
- $534M raised — one of the best-funded medical AI companies in the world
- Dozens of FDA clearances — most extensively cleared AI imaging portfolio available
- PACS-agnostic — works with any existing radiology infrastructure
- Gartner Cool Vendor and named in multiple industry AI leadership reports
- CARE1 foundation model and BRIDGE/NVIDIA framework for next-gen AI deployment
Cons
- Enterprise-only — not available for small clinics or independent radiologists
- No published pricing — requires sales engagement for quotes
- Requires integration with existing PACS and EHR infrastructure
- Deployment and onboarding can take weeks to months for large systems
- AI recommendations still require radiologist review and sign-off
Viz.ai Pros & Cons
Pros
- 12 FDA-cleared algorithms — broadest acute-condition AI portfolio in its class
- Medicare NTAP reimbursement pathway — unique among AI imaging platforms
- 44% reduction in DIDO times for stroke patients — peer-reviewed clinical evidence (ISC 2026)
- 1,000+ hospital deployments across U.S. and Europe
- Backed by Google Ventures, Kleiner Perkins, and Tiger Global — $289M raised
- Simultaneous mobile alerts to full care team — no phone-tag delays
- Expands from neurology to cardiology and pulmonology in one unified platform
Cons
- Enterprise-only pricing — no self-serve or small clinic access
- No published pricing — all contracts are custom
- Primarily focused on acute/time-sensitive conditions — not general radiology reads
- Requires integration with existing hospital imaging infrastructure
- Implementation and onboarding take time for large multi-site systems
AI Verdict
In the rapidly evolving landscape of clinical AI, Aidoc and Viz.ai stand out as leading innovators, each approaching the challenge of integrating artificial intelligence into medical imaging workflows with distinct philosophies. Aidoc, with its robust aiOS platform and CARE1 foundation model, positions itself as a comprehensive, unified clinical AI infrastructure for radiology triage and enterprise deployment. It boasts an impressive portfolio of dozens of FDA-cleared algorithms, analyzing over 60 million patient cases annually across nearly 2,000 hospitals. Aidoc's strength lies in its ability to integrate seamlessly with any PACS/EHR system via HL7/FHIR, providing real-time analysis across a broad spectrum of acute conditions—from stroke and PE to aortic dissection, fractures, and cardiac diseases. Its ultimate goal is to offer a scalable, all-encompassing AI layer that enhances the entire radiology department's efficiency and patient care coordination. This makes Aidoc ideal for large hospital networks seeking a single, powerful AI backbone for their imaging diagnostics and population health initiatives.
Conversely, Viz.ai excels as a specialized AI care coordination platform primarily focused on time-sensitive medical conditions like acute stroke, pulmonary embolism, and aortic dissection. Deployed in over 1,000 hospitals, Viz.ai's core differentiator is its proven ability to drastically reduce time-to-treatment by analyzing CT scans in minutes and simultaneously alerting the entire care team—neurologist, ED physician, interventionalist—via a HIPAA-compliant mobile app. This workflow-centric approach has led to significant clinical outcomes, such as a 44% reduction in door-in-door-out (DIDO) times for LVO stroke patients, backed by peer-reviewed evidence. Viz.ai is particularly well-suited for hospitals and health systems where rapid, coordinated intervention for acute emergencies is paramount, offering a targeted solution that optimizes critical care pathways and even provides a Medicare NTAP reimbursement pathway, offsetting platform costs. While both leverage FDA-cleared AI for imaging analysis, Aidoc offers a broader, enterprise-wide radiology AI platform, whereas Viz.ai provides a highly optimized, acute care coordination engine.
Frequently Asked Questions
QWhat is the primary difference in how Aidoc and Viz.ai integrate into a hospital's existing systems?
Aidoc integrates as a comprehensive aiOS platform with any PACS, EHR, or workflow system via HL7/FHIR, aiming for a unified AI infrastructure across radiology. Viz.ai also integrates with hospital imaging systems but focuses more on real-time analysis and mobile alerts for care team coordination for acute cases.
QWhich platform is better for optimizing the entire radiology department versus acute care pathways?
Aidoc is generally better for optimizing the entire radiology department due to its broad coverage of conditions, population health tools, and enterprise AI framework. Viz.ai excels specifically at optimizing acute care pathways for time-sensitive conditions like stroke, PE, and aortic dissection, focusing on rapid response and team coordination.
QDo both Aidoc and Viz.ai require FDA clearance for their algorithms?
Yes, both Aidoc and Viz.ai develop and deploy FDA-cleared algorithms for clinical use, ensuring their AI detections and analyses meet rigorous safety and efficacy standards for medical devices.
QIs there a free trial or published pricing for either Aidoc or Viz.ai?
No, both Aidoc and Viz.ai operate on custom enterprise contracts with hospitals and health systems. There is no published pricing or self-serve option; interested parties must contact their respective sales teams for a demo and tailored quote.
QHow do these platforms help with hospital reimbursement or cost savings?
Viz.ai uniquely offers a Medicare New Technology Add-on Payment (NTAP) designation, providing hospitals with additional reimbursement per qualifying patient encounter. Aidoc's value comes from improving operational efficiency, reducing time-to-treatment, and enhancing patient outcomes across a broader range of conditions, which can lead to indirect cost savings and improved hospital performance metrics.
Popular Comparisons
Direct feature matrices, pricing breakdowns, and real-world benchmark duels
